Company intelligence / Profile preview

Mangoceuticals, Inc.

Dallas, Texas, United Statesmangoceuticals.com ↗

Ownership: Public · MGRX
Development stage: Commercial

Overview

Mangoceuticals operates through its telemedicine platforms MangoRx and PeachesRx, offering prescription services for various health conditions. The company recently acquired Smokeless Technology IP to enter the nutraceutical pouch delivery space and has expanded into the diabetes market.

Therapeutic areas: Men's HealthEndocrinologyDermatology
Modalities: Compounded pharmaceuticalsNutraceuticals
Industry: Non-Academic Healthcare

Drug pipeline

3 assets

sildenafil + oxytocin + L-arginine

Commercial

Indications: Erectile dysfunction

2 more assets in the full pipeline.

Request access →

Partnerships

Partner compounding pharmacy (unnamed)

Financials

Market cap: $7.1M
Total revenue: $68.8K
Enterprise value: $7.2M

Beyond the preview

Go deeper on Mangoceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mangoceuticals, Inc..

Explore the full profile